Ipca Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ETODOLAC USP (ED6 PROCESS), with a corresponding US DMF Number 24868.
Remarkably, this DMF maintains an Active status since its submission on May 02, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 07, 2013, and payment made on March 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II